<DOC>
	<DOCNO>NCT01404390</DOCNO>
	<brief_summary>This study conduct open label , single centre , Phase I study PI3K ( phosphatidyl inositol 3 kinase ) inhibitor BAY80-6946 Japanese patient advanced refractory solid tumour . The eligible subject dose intravenously Day 1 , Day 8 Day 15 three week one week treatment cycle .</brief_summary>
	<brief_title>Japanese BAY80-6946 Monotherapy Phase I Study</brief_title>
	<detailed_description />
	<criteria>Cancer patient Japanese patient , least 20 year age Histological cytological documentation nonhematologic , malignant solid tumour , exclude primary brain spinal tumour , past current involvement central nervous system ( CNS ) At least one measurable lesion evaluable disease accord RECIST ( version 1.1 ) Eastern Cooperative Oncology performance status ( ECOGPS ) 0 1 Life expectancy least 12 week Advanced refractory solid tumour amenable standard therapy , first screen examination/visit Anticancer chemotherapy immunotherapy study within 4 week first study treatment . Patients must recover toxic effect previous anticancer chemotherapy immunotherapy investigator ( exception alopecia ) . Radiotherapy target lesion study within 4 week first study treatment Investigational drug therapy outside trial within 4 week first study treatment Current diagnosis Type I II diabetes mellitus fast blood glucose level &gt; 125 mg/dL screening , and/or HbA1c &gt; /= 6.5 % Past current history cardiac disease congestive heart failure &gt; New York Heart Association ( NYHA ) Class II ; active coronary artery disease , myocardial infarction within 6 month prior study entry ; new onset angina within 3 month prior study entry unstable angina ventricular cardiac arrhythmia require antiarrhythmic therapy Active clinically serious infection &gt; Grade 2 ( National Cancer Institute Common Terminology Criteria Adverse Events [ NCICTCAE ] version 4.03 ) Uncontrolled hypertension define systolic blood pressure &gt; 150 mm Hg diastolic pressure &gt; 90 mm Hg , despite optimal medical management Patients undergo renal dialysis Pregnant breast feeding woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Japanese</keyword>
</DOC>